Last reviewed · How we verify
SIM0505 for injection — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
SIM0505 for injection (SIM0505 for injection) — NextCure, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| SIM0505 for injection TARGET | SIM0505 for injection | NextCure, Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- SIM0505 for injection CI watch — RSS
- SIM0505 for injection CI watch — Atom
- SIM0505 for injection CI watch — JSON
- SIM0505 for injection alone — RSS
Cite this brief
Drug Landscape (2026). SIM0505 for injection — Competitive Intelligence Brief. https://druglandscape.com/ci/sim0505-for-injection. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab